Biom'up

Biom'up completed the 2018 scale-up of its manufacturing facility near Lyon, France, upgrading six key processes to increase throughput for HEMOBLAST Bellows. Product output grew to over 4,000 units per month in October 2018.

Biom'up announced plans to build a new 7,000 m² production facility in the Lyon region, France, with an investment of €15 million. The plant is expected to produce one million units of its Hemoblast TM Bellows hemostatic device and create 150-200 jobs.